ArticlePharmaceutics2022

Transcutaneous Administration of Imiquimod Promotes T and B Cell Differentiation into Effector Cells or Plasma Cells.

Sachiko Hirobe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.